Table 4.

Correlation analysis among the GSLs analyzed in this study (n = 146).

GSLs	PRO	EPI	SIN	GRA	GNA	4HGBS	GER	GBS	4MGBS	GNS	NGBS	Total GSL
GIB	−0.285**	−0.131	0.598**	−0.485**	−0.273**	0.192*	−0.318**	0.239**	−0.112	0.272**	0.254**	0.576**
PRO		0.686**	−0.106	0.360**	0.805**	0.073	0.254**	0.099	−0.141	−0.031	−0.061	0.280**
EPI			−0.065	0.260**	0.592**	0.032	0.192*	0.231**	−0.195*	−0.001	−0.097	0.296**
SIN				−0.555**	−0.050	0.110	−0.271**	0.006	−0.180*	0.263**	0.113	0.658**
GRA					0.199*	−0.008	0.555**	0.193*	0.336**	−0.069	−0.010	−0.061
GNA						0.016	0.202*	−0.015	−0.183*	-0.052	−0.088	0.214**
4HGBS							−0.063	0.143	0.130	0.085	0.062	0.229**
GER								0.045	0.251**	−0.164*	−0.059	−0.019
GBS									0.089	0.132	0.411**	0.654**
4MGBS										−0.028	0.028	−0.017
GNS											0.110	0.308**
NGBS	□	□	□	□	□	□	□	□	□	□	□	0.393**

*,** Correlation is significant at P = 0.05 and 0.01, respectively. GSLs: glucosinolates; GIB: glucoiberin; PRO: progoitrin; EPI: epi-progoitrin; SIN: sinigrin; GRA: glucoraphanin; GNA: gluconapin; GER: glucoerucin; 4HGBS: 4-hydroxyglucobrassicin; GBS: glucobrassicin; 4MGBS: 4-methoxyglucobrassicin; NGBS: neoglucobrassicin; GNS: gluconastrutiin.